期刊文献+

2型糖尿病患者血清维生素D水平与甲状腺功能的关系研究 被引量:23

Relationship between thyroid function and serum vitamin D levels in type 2 diabetic patients
原文传递
导出
摘要 选取甲状腺自身抗体阴性的2型糖尿病患者180例,根据血25羟维生素D[25(OH)D]水平分为维生素D正常组(≥30ng/ml)18例、不足组(20-〈30ng/m1)34例、缺乏组(10~〈20ng/ml)46例及严重缺乏组(〈10ng/ml)82例。结果显示,维生素D严重缺乏组的TT3、FT3、FT33/FT4比值及TSH水平均明显高于维生素D正常组。经校正性别、年龄及体重指数后,血25(OH)D水平与TSH呈负相关(r=-0.207,P〈0.05)。多元线性回归分析显示血25(OH)D是预测TSH水平的独立危险因素(β=-0.201,P〈0.05),提示2型糖尿病患者的维生素D水平与甲状腺功能相关。 A total of 180 type 2 diabetic patients with negative anti-thyroid autoantibodies were recruited. According to the levels of serum 25-OH vitamin D [ 25 ( OH ) D ] , these patients were divided into four groups: sufficient group( ≥30 ng/ml), insufficient group(20-〈30 ng/ml) , deficiency group( 10-〈20 ng/ml), and severe deficiency group( 〈10 ng/ml). The results showed that compared with sufficient vitamin D group, the group with severe deficient vitamin D had higher TT3, FT3, FT3/FT4, and TSH ( all P〈0.05 ). The serum 25 (OH) D level was negatively correlated with TSH values ( r = -0. 207, P〈0.05 ) after adjustment for gender, age, and body mass index. Multivariate regression analysis indicated that serum 25 (OH) D level was an independent influencing factor for TSH value (β = -0.201, P〈0.05 ), suggesting that serum 25 (OH) D level seems to be correlated with thyroid function in type 2 diabetic patients.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2015年第3期245-248,共4页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金项目(81270369) 首都临床特色基金(Z131107002213024)
关键词 维生素D缺乏 糖尿病 2型 甲状腺功能 Vitamin D deficiency Diabetes mellitus, type 2 Thyroid function
  • 相关文献

参考文献28

  • 1Holick MF. Vitamin D deficiency [J ]. N Engl J Med, 2007,357 ( 3 ) : 266-281.
  • 2Davies JH, Shaw NJ. Preventable but no strategy : vitamin D deficiency in the UK[J]. Arch Dis Child, 2011,96(7) :614-615.
  • 3张巧,彭年春,徐淑静,张淼,庄惠君,张璟璐,刘柳,时立新.贵阳城区成人维生素D营养状况调查[J].中华内分泌代谢杂志,2011,27(8):659-663. 被引量:45
  • 4Yu JR, Lee SA, Lee JG, et al. Serum vitamin D status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus[ J]. Chonnam Med J, 2012,48(2) :108-115.
  • 5Karhapaa P, Pihlajamaki J, Porsti I, et al. Diverse associations of 25- hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias [J]. J Intem Med, 2010,268(6) :604-610.
  • 6Park HY, Lim YH, Kim JH, et al. Association of serum 25- hydroxyvitamin D levels with markers for metabolic syndrome in the elderly : a repeated measure analysis [ J ]. J Korean Med Sei, 2012,27 (6) :653-660.
  • 7Wang TJ, Pencina M J, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease [ J ]. Circulation, 2008,117 (4) :503-511.
  • 8林寰东,高键,马慧,李小明,宋斌斌,潘柏申,盛建华,陈旭昇,高鑫.中老年人群25-羟维生素D与代谢综合征关系的研究[J].中华内分泌代谢杂志,2013,29(10):840-845. 被引量:9
  • 9Penna G, Adorini L. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation [ J ]. J Immunol, 2000, 164 ( 5 ) : 2405-2411.
  • 10Berg JP, Liane KM, Bjorhovde SB, et al. Vitamin D receptor binding and biological effects of cholecalciferol analogues in rat thyroid cells [ J ]. J Steroid Biochem Mol Biol, 1994,50 ( 3-4 ) : 145 -150.

二级参考文献19

  • 1Haffner SM. The metabolic syndrome : inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol, 2006,97 (2A) : 3 A-11A.
  • 2Grundy SM, Cleeman J1, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Crit Pathw Cardiol, 2005,4 .. 198-203.
  • 3Deluca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr, 2004,80(6 Suppl) :1689S-1696S.
  • 4Holick MF. Vitamin D deficiency. N Engl J Med, 2007,357 : 266-281.
  • 5Hyppnen E, Boucher B J, Berry D J, et al. 25-hydroxyvitamin D, IGF- 1, and metabolic syndrome at 45 years of age : a cross-sectional study in the 1958 British Birth Cohort. Diabetes, 2008,57:298-305.
  • 6Ford ES, Ajani UA, Mcguire LC, et al. Concentrations of serum vitamin D and the metabolic syndrome among U. S. adults. Diabetes Care, 2005,28 : 1228-1230.
  • 7Lu L, Yu Z, Pan A, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care, 2009,32:1278-1283.
  • 8Kayaniyil S, Vieth R, Harris SB, et al. Association of 25 ( OH ) D and PTH with metabolic syndrome and its traditional and nontraditional components. J Clin Endocrinol Metab, 2011,96 : 168-175.
  • 9Reis JP, yon Mt|hlen D, Kritz-Silverstein D, et al. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care, 2007,30 : 1549- 1555.
  • 10Hjelmesaeth J, Hofs D, Aasheim ET, et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol, 2009,8:7.

共引文献52

同被引文献192

引证文献23

二级引证文献148

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部